Shanghai Henlius Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,667	5,724	5,395	3,215	1,682
Revenue Growth (YoY)	16.46%	6.11%	67.82%	91.07%	186.34%
Cost of Revenue	1,682	1,540	1,476	844.62	522.75
Gross Profit	4,985	4,185	3,919	2,370	1,160
Selling, General & Admin	2,642	2,288	2,138	1,403	800.87
Research & Development	1,515	1,035	1,119	1,395	1,024
Operating Expenses	4,168	3,318	3,266	2,999	1,825
Operating Income	817.12	866.5	652.95	-628.53	-665.25
Interest Expense	-102.49	-122.89	-110.54	-105.67	-84.82
Interest & Investment Income	18.79	21.7	8.15	3.57	2.69
Currency Exchange Gain (Loss)	-	8.14	-1.42	32.92	-
Other Non Operating Income (Expenses)	78.3	72.43	20.44	202.97	-209.36
EBT Excluding Unusual Items	811.72	845.88	569.58	-494.73	-956.74
Gain (Loss) on Sale of Investments	-	-	-	-199.15	-
Pretax Income	811.72	845.88	569.58	-693.89	-956.74
Income Tax Expense	-15.32	25.41	23.56	1.37	27.31
Earnings From Continuing Operations	827.04	820.47	546.02	-695.26	-984.05
Net Income	827.04	820.47	546.02	-695.26	-984.05
Net Income to Common	827.04	820.47	546.02	-695.26	-984.05
Net Income Growth	0.80%	50.26%	-	-	-
Shares Outstanding (Basic)	543	543	543	542	539
Shares Outstanding (Diluted)	546	543	543	542	539
Shares Change (YoY)	0.45%	0.02%	0.25%	0.59%	1.75%
EPS (Basic)	1.52	1.51	1.01	-1.28	-1.83
EPS (Diluted)	1.51	1.51	1.00	-1.28	-1.83
EPS Growth	0.03%	50.96%	-	-	-
Free Cash Flow	-	1,078	574.25	396.65	-370.04
Free Cash Flow Per Share	-	1.98	1.06	0.73	-0.69
Gross Margin	74.77%	73.10%	72.64%	73.73%	68.93%
Operating Margin	12.26%	15.14%	12.10%	-19.55%	-39.54%
Profit Margin	12.41%	14.33%	10.12%	-21.63%	-58.49%
Free Cash Flow Margin	-	18.83%	10.64%	12.34%	-21.99%
EBITDA	1,112	1,162	932.58	-419.93	-518.3
EBITDA Margin	16.69%	20.29%	17.29%	-13.06%	-30.80%
D&A For EBITDA	295.29	295.29	279.63	208.6	146.95
EBIT	817.12	866.5	652.95	-628.53	-665.25
EBIT Margin	12.26%	15.14%	12.10%	-19.55%	-39.54%
Effective Tax Rate	-	3.00%	4.14%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.